| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 178 |
| 1 | EVEROLIMUS | 177 |
| 2 | SUNITINIB MALATE | 79 |
| 3 | LUTETIUM LU 177 DOTATATE | 78 |
| 4 | METFORMIN | 56 |
| 5 | EVEROLIMUS TABLETS | 55 |
| 6 | METFORMIN ER 500 MG | 55 |
| 7 | METFORMIN ER 750 MG | 55 |
| 8 | CAPECITABINE | 52 |
| 9 | ERGOCALCIFEROL | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOZOCIN | 37 | 0.1609 |
| 1 | LUTETIUM LU 177 DOTATATE | 78 | 0.0134 |
| 2 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 3 | 0.0062 |
| 3 | OCTREOTIDE ACETATE | 178 | 0.0058 |
| 4 | SODIUM CITRATE | 5 | 0.0040 |
| 5 | EVEROLIMUS | 177 | 0.0036 |
| 6 | EVEROLIMUS TABLETS | 55 | 0.0032 |
| 7 | SUNITINIB MALATE | 79 | 0.0020 |
| 8 | PENICILLIN V POTASSIUM | 5 | 0.0019 |
| 9 | ERGOCALCIFEROL | 49 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 181 |
| 1 | mTOR Inhibitor Immunosuppressant [EPC] | 177 |
| 2 | GLP-1 Receptor Agonist [EPC] | 65 |
| 3 | Alkylating Drug [EPC] | 61 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 61 |
| 5 | Corticosteroid [EPC] | 55 |
| 6 | Provitamin D2 Compound [EPC] | 49 |
| 7 | Somatostatin Analog [EPC] | 45 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 44 |
| 9 | Proton Pump Inhibitor [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 45 | 0.0065 |
| 1 | Provitamin D2 Compound [EPC] | 49 | 0.0016 |
| 2 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 3 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 3 | 0.0007 |
| 5 | Glinide [EPC] | 5 | 0.0006 |
| 6 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 7 | Kinase Inhibitor [EPC] | 181 | 0.0003 |
| 8 | Alkylating Drug [EPC] | 61 | 0.0003 |
| 9 | Topoisomerase Inhibitor [EPC] | 19 | 0.0002 |